Danaher Corporation (DHR) : Hm Payson Co scooped up 7,965 additional shares in Danaher Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 8, 2016. The investment management firm now holds a total of 193,017 shares of Danaher Corporation which is valued at $15,738,606.Danaher Corporation makes up approximately 0.76% of Hm Payson Co’s portfolio.
Other Hedge Funds, Including , William Blair Investment Management boosted its stake in DHR in the latest quarter, The investment management firm added 26,378 additional shares and now holds a total of 1,488,957 shares of Danaher Corporation which is valued at $121,409,554. Danaher Corporation makes up approx 0.45% of William Blair Investment Management’s portfolio. Meag Munich Ergo Kapitalanlagegesellschaft Mbh added DHR to its portfolio by purchasing 31,583 company shares during the most recent quarter which is valued at $2,572,120. Danaher Corporation makes up approx 0.23% of Meag Munich Ergo Kapitalanlagegesellschaft Mbh’s portfolio.Checchi Capital Advisers boosted its stake in DHR in the latest quarter, The investment management firm added 155 additional shares and now holds a total of 5,651 shares of Danaher Corporation which is valued at $459,087. Danaher Corporation makes up approx 0.11% of Checchi Capital Advisers’s portfolio.Fcm Investmentstx reduced its stake in DHR by selling 79 shares or 0.15% in the most recent quarter. The Hedge Fund company now holds 54,211 shares of DHR which is valued at $4,404,102. Danaher Corporation makes up approx 2.54% of Fcm Investmentstx’s portfolio.
Danaher Corporation closed down -0.16 points or -0.20% at $81.23 with 29,26,567 shares getting traded on Monday. Post opening the session at $81.73, the shares hit an intraday low of $81.15 and an intraday high of $81.79 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, Danaher Corporation reported $1.25 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 25, 2016. Analyst had a consensus of $1.22. The company had revenue of $5785.00 million for the quarter, compared to analysts expectations of $5766.84 million. The company’s revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.08 EPS.
Many Wall Street Analysts have commented on Danaher Corporation. Shares were Reiterated by Barclays on Jul 11, 2016 to “Overweight” and Lowered the Price Target to $ 86 from a previous price target of $105 .Danaher Corporation was Initiated by Goldman to “Neutral” on Jul 5, 2016. Danaher Corporation was Upgraded by Bernstein to ” Outperform” on Jun 24, 2016.
Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products. The Environmental segment products and services help protect the global water supply facilitate environmental stewardship and enhance the safety of personal data. The Companys diagnostics business offers analytical instruments reagents consumables software and services. The Dental segment provides products that are used to diagnose treat and prevent disease and ailments of the teeth gums and supporting bone. The Companys Industrial Technologies solutions help protect the worlds food supply improve packaging design and quality verify pharmaceutical dosages and authenticity and power innovative machines.